HF
AVXL icon

HRT Financial’s Anavex Life Sciences AVXL Stock Holding History

HRT Financial’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-657,877
Closed -$1.95M – 4174
2026
Q1 		$2.02M Buy
+657,877
New +$2.85M 0.01% 1612
2024
Q4 		– Sell
-92,163
Closed -$523K – 2427
2024
Q3 		$523K Sell
92,163
-2,041
-2% -$11.8K ﹤0.01% 1565
2024
Q2 		$397K Buy
+94,204
New +$381K ﹤0.01% 1393
2022
Q3 		– Sell
-44,822
Closed -$448K – 2782
2022
Q2 		$448K Buy
+44,822
New +$425K ﹤0.01% 1741

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HRT Financial's AVXL Position: Q2 2026 in Review

HRT Financial sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 657,877 shares — an estimated $1.95M sold.

HRT Financial first reported a position in AVXL in Q2 2022 and held it in 4 quarters. The position peaked at $2.02M in Q1 2026. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • HRT Financial reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 657,877 Anavex Life Sciences shares in Q2 2026, an estimated $1.95M.
  • HRT Financial first reported a position in Anavex Life Sciences in Q2 2022 and held it in 4 quarters.
  • HRT Financial's Anavex Life Sciences position peaked at $2.02M in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.